NEU 4.29% $17.03 neuren pharmaceuticals limited

nnz-2556 multi-acting medicine, page-4

  1. 10,009 Posts.
    If they can prevent or reduce post traumatic seizures, in frequency or strength they will get approved.

    Any improvement in any area, will get this drug approved. This is unmet need.

    The bar is very low, and won't take much to jump over it.

    It does not have to cure anything. As was posted earlier today, a cocktail of drugs will eventually be the treatment.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.